Research Article

Study on the Intervention Effect of Qi Gong Wan Prescription on Patients with Phlegm-Dampness Syndrome of Polycystic Ovary Syndrome Based on Intestinal Flora

Table 2

Comparison of clinical baseline data before and after treatment in PCOS patients with phlegm-dampness.

CharacteristicPCOS with phlegm-dampness group before treatment (n = 20)PCOS with phlegm-dampness group after treatment (n = 20) value value

BMI (kg/m2)32.23 ± 5.0629.56 ± 3.93−3.921 < 0.001
Waist circumference (cm)88.8 ± 6.1682.05 ± 5.09−3.924 < 0.001
Hip circumference (cm)99.9 ± 2.6598.3 ± 2.13−3.3350.001
WHR0.89 ± 0.040.83 ± 0.04−3.893 < 0.001
FPG (mmol/L)5.8 ± 0.55.37 ± 0.35−3.1050.002
FINS (μU/mL)22.66 ± 10.6613.27 ± 5.89−3.743 < 0.001
HOMA-IR5.94 ± 3.023.18 ± 1.47−3.783 < 0.001
FSH (mIU/mL)6.59 ± 1.276.78 ± 0.97−0.5040.614
LH (mIU/mL)10.77 ± 3.156.83 ± 2.06−3.883 < 0.001
LH: FSH ratio1.66 ± 0.491.02 ± 0.31−3.921 < 0.001
Prolactin (ng/mL)11.45 ± 6.6210.62 ± 4.95−0.8030.422
Testosterone (ng/mL)0.74 ± 0.240.65 ± 0.15−1.1950.232

Data are presented as mean ± SD. Abbreviation: PCOS, polycystic ovary syndrome; BMI, body mass index; WHR: waist-to-hip ratio; FPG, fasting plasma glucose; FINS, fasting plasma insulin; HOMA-IR, homeostasis model assessment of insulin resistance; FSH, follicular stimulating hormone; LH, luteinizing hormone. There is a significant difference between the two groups (<0.05); difference is highly significant (<0.01).